Form 4 for PCSA Processa Pharmaceuticals, Inc.
Accepted 2021-08-09 00:00:00 ET · period of report 2021-08-05 · accession 0001567619-21-014741 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-08-09 | 2021-08-05 | PCSA | Young David | CEO, Dir, 10% | A - Grant | — | +7,601 | 382.0K | +2% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-08-05 | A | A | 7,601 | — | 381,964 | D | — | — | (F1) Vesting of time-based restricted shares. |